Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Fragile underlying quality score of 33/100; weak margins or elevated debt leverage warrant caution.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Mixed fundamental profile with offsetting strengths and weaknesses.
Wall Street is cautious, forecasting potential downside. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
FNWB demonstrates adequate business quality with stable profitability. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (3.8%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $27.3M | -8.4% | — | — | +10.8% | |
| EBITDA | $4K | — | — | — | — | |
| Net Income | $6K | +36.6% | — | — | — | |
| EPS (Diluted) | $0.00 | +36.0% | — | — | — | |
| Free Cash Flow | $440K | -91.5% | -52.1% | -34.0% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 55.0% | 48.8% | 64.9% | 75.0% |
| Operating Margin | 3.8% | -3.1% | 6.3% | 11.9% |
| Net Margin | 4.7% | -2.5% | 5.9% | 9.3% |
| FCF Margin | 18.8% | 10.4% | 11.4% | 12.8% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.03 | $0.00 | -97.7% | ||
| Q1'26 | $0.09 | $0.04 | -55.6% | ||
| Q4'25 | $0.18 | $0.09 | -50.0% | ||
| Q3'25 | $0.09 | $0.42 | +366.7% | ||
| Q2'25 | $0.12 | $0.17 | +41.7% | ||
| Q1'25 | $0.06 | $-0.32 | -633.3% | ||
| Q4'24 | $0.10 | $-0.23 | -330.0% | ||
| Q3'24 | $0.08 | $0.16 | +100.0% |
Total return is +36.4% (1Y), outperforming the benchmark by +15.6%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +12.3% | +5.0% | — |
| 1Y | +36.4% | +15.6% | — |
| 3YCAGR | -0.3% | -19.5% | +5.1% |
| 5YCAGR | -8.2% | -19.9% | +6.3% |
| 10YCAGR | -0.5% | -14.5% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about First Northwest Bancorp (FNWB) valuation, health, and returns.
Based on peer relative multiples, First Northwest Bancorp appears Slightly expensive versus peers compared to industry peers.
First Northwest Bancorp has multiple valuation anchors: Peer Relative Fair Value: $8.59 | Wall Street Analyst Target: $8.00 (implying -23.8% upside). A convergence of these signals offers higher conviction.
First Northwest Bancorp displays weak financial health with a composite quality score of 33/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of -0.9%.
First Northwest Bancorp pays a 1.3% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 0.0% buyback yield.
First Northwest Bancorp's current growth trajectory is Stable. The company achieved -8.4% 1Y revenue growth and +36.0% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Buy based on 1 analysts, beating EPS expectations in 25% of recent quarters with a -3-quarter streak. The consensus price target represents a -23.8% change from current levels.
Investment risks for First Northwest Bancorp include: -22.2% 1-year max drawdown. Volatility risk is characterized by a beta of 0.51x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.